BONFANTI PAOLO

Fusco, F., Mastrorosa, I., Vichi, F., Cervo, A., Saracino, A., Calza, L., et al. (2026). HIV infection among adolescents and young adults in Italy: Epidemiology, viro-immunological and treatment outcomes. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 163(February 2026) [10.1016/j.ijid.2025.108200]. Dettaglio

Calcagno, A., Candela, C., Riva, A., Calza, S., Fioretti, B., Gardini, S., et al. (2026). Bimonthly Administered Long-Acting Cabotegravir and Rilpivirine Are Highly Effective and Well-Tolerated in People With Human Immunodeficiency Virus Above 65 Years. OPEN FORUM INFECTIOUS DISEASES, 13(1) [10.1093/ofid/ofaf817]. Dettaglio

Augello, M., Bartolomeo, F., Varisco, B., Timelli, L., Bartoletti, M., Bonfanti, P., et al. (2026). Real-world use of cefiderocol as monotherapy or combination therapy for the treatment of Gram-negative bacterial infections: the multicentre retrospective CEFI-BAC study. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 163(February 2026) [10.1016/j.ijid.2025.108305]. Dettaglio

Squillace, N., Ricci, E., Maggi, P., Taramasso, L., Menzaghi, B., Sarchi, E., et al. (2025). Safety and durability of treatment with Bictegravir/Emtricitabine/Tenofovir Alafenamide in a real-life cohort. Intervento presentato a: 20th European AIDS Conference (EACS), Parigi. Dettaglio

Ripamonti, D., Comi, L., Francavilla, A., Valenti, D., Cossu, M., Moschese, D., et al. (2025). Potential for replacing protease inhibitor with doravirine in cART-experienced subjects successfully treated with darunavir-cobicistat plus dolutegravir dual regimen. Intervento presentato a: 20th European AIDS Conference (EACS), Parigi. Dettaglio